Neuroelectrics

PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 08/02/2019

Pipeline Type

New Therapeutic Devices

Phase Of Development

N/A

Sponsors and Collaborators

Neuroelectrics Corporation; Rennes Hospital; Boston Childrens

Mechanism of Action

Mechanism Description

Transcranial Direct Current Stimulation

Populations Tested In

Mesial Temporal Lobe Epilepsy; drug resistant focal epilepsy

Other Resources

Special FDA Designation

Nonprofit or Government Support

N/A

Nonprofit or Government Support Description

N/A

Previous Presentations

Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
AEDD 2019

Location of Clinical Trials

Rennes, France; Boston, MA, USA

Join Our Newsletter

Want to get notified about new devices? Stay up to date with the latest epilepsy news and stories from the community.